-
Predicted Top 5 Worldwide Selling Drugs in 2025: A Market Update
David Orchard-Webb
June 23, 2025
Keytruda ($30B sales), Ozempic, Mounjaro, Dupixent, and Skyrizi dominate 2025's pharma market, targeting oncology, diabetes/obesity, and immunology with breakthrough biologics and multi-indication strategies.
-
Diabetes and Metabolic Disorders: The Approval of Teplizumab
David Orchard-Webb
June 23, 2025
Teplizumab, the first disease-modifying therapy for Type 1 diabetes, delays disease onset by ~4 years in high-risk individuals. Priced at $194,000 per course, it redefines early intervention despite cost barriers.
-
Pharmacovigilance Regulations and Application: Safeguarding Drug Safety in a Complex Global Environment
David Orchard-Webb
May 06, 2025
In a pharmaceutical world characterized by rapid innovation and international marketplaces, safeguarding medication safety beyond commercialization has never been more important.
-
Sterilization Processes in the Pharmaceutical Industry
David Orchard-Webb
May 06, 2025
In this post, we'll look at the numerous sterilization techniques utilized in the pharmaceutical sector, as well as their uses and benefits in terms of product safety and regulatory compliance.
-
The Transformative Role of Blockchain in the Pharmaceutical Industry
David Orchard-Webb
April 21, 2025
The pharmaceutical business, long considered one of the most regulated and difficult sectors, is experiencing a digital transition.
-
The Global ESG Rules and Regulations in the Pharmaceutical Industry: AstraZeneca Case Study
David Orchard-Webb
April 21, 2025
In the dynamic pharmaceutical sector, where innovation and regulatory compliance have long been the pillars of success, a new disruptive force is emerging: Environmental, Social, and Governance (ESG) principles
-
Global Shingles (Herpes Zoster) Market Trends and Prospects
David Orchard-Webb
March 18, 2025
The global shingles market is growing due to factors like an aging population. It elaborates on drivers, segmentation, competition, and future trends.
-
The Global Alpha-Glucosidase Inhibitor Market: Trends and Prospects
David Orchard-Webb
March 18, 2025
Alpha-glucosidase inhibitors are used for type 2 diabetes. This article analyzes their market, including growth, segments, and challenges.
-
What Are Insulinotropic Polypeptides? How Are They Regulated?
David Orchard-Webb
February 07, 2025
Insulinotropic polypeptides like GIP and GLP-1 regulate insulin secretion. Retatrutide shows promise in treating obesity and MASLD. Related drugs face regulatory scrutiny and market is growing.
-
Top Generalizable Antivirals for Stockpiling in Emergencies: A Review and Gap Analysis
David Orchard-Webb
February 06, 2025
Reviews top generalizable antivirals for emergency stockpiling, analyzes their pros & cons, and points out gaps in antiviral stockpile.